PRESS RELEASE published on 06/03/2024 at 20:59, 2 years 2 months ago Informations privilégiées / Autres communiqués Ikonisys réalise une augmentation de capital par le biais d'un placement privé pour accélérer son développement commercial. L'émission de 100 000 actions nouvelles permettra de renforcer ses ressources financières Placement Privé Augmentation De Capital Actions Nouvelles Développement Commercial Ikonisys
BRIEF published on 05/30/2024 at 07:35, 2 years 2 months ago Ikonisys Launches New Website to Promote FISH Technology and Total Automation in Healthcare Automation Healthcare Ikonisys FISH Technology Mass Screening
BRIEF published on 05/30/2024 at 07:35, 2 years 2 months ago Ikonisys lance un nouveau site Web pour promouvoir la technologie FISH et l'automatisation totale des soins de santé Automatisation Soins De Santé Ikonisys Technologie POISSON Dépistage De Masse
PRESS RELEASE published on 05/30/2024 at 07:30, 2 years 2 months ago Inside Information / Other news releases Ikonisys launches new website focusing on FISH technology and total automation in healthcare, enhancing mass cancer screening with advanced solutions and seamless integration Healthcare Ikonisys FISH Technology Mass Screening Total Automation
BRIEF published on 05/15/2024 at 07:35, 2 years 2 months ago Ikonisys : Nouveau brevet international pour Hospitex Ikonisys Hospitex International BLOCKfast Brevet International Diagnostic Du Cancer
BRIEF published on 05/15/2024 at 07:35, 2 years 2 months ago Ikonisys: New international patent for Hospitex Ikonisys BLOCKfast Hospitalex International International Patent Cancer Diagnosis
PRESS RELEASE published on 05/15/2024 at 07:30, 2 years 2 months ago Informations privilégiées / Autres communiqués Hospitex obtient un brevet international pour kit cytoinclusion BLOCKfast, produit phare utile en anatomie pathologique, ouvrant perspectives de développement commercial mondial Hospitex Développement Commercial BLOCKfast Brevet International Diagnostic Cancer
PRESS RELEASE published on 05/15/2024 at 07:30, 2 years 2 months ago Inside Information / Other news releases Hospitex International obtains international patent for BLOCKfast cyto-inclusion kit, enhancing global cancer diagnosis solutions. Company offers innovative diagnostics solutions in cytology Hospitex International BLOCKfast Cyto-inclusion Kit Global Commercial Development Cancer Diagnosis Solutions Cytology Diagnostics
PRESS RELEASE published on 02/06/2024 at 10:11, 2 years 6 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Ikonisys SA receives Buy recommendation and increased price target to EUR 6.30 from EUR 4.50 per share after acquiring Hospitex, an Italian-based cytology company Acquisition Strategic Partnership Ikonisys SA Hospitex Cancer Diagnostics
PRESS RELEASE published on 11/01/2023 at 11:26, 2 years 9 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
Published on 08/14/2026 at 13:30, 1 hour 18 minutes ago Digi Power X Reports Second Quarter 2026 Financial Results and Provides Operational Update and 2027 Outlook
Published on 08/14/2026 at 13:15, 1 hour 33 minutes ago Mako Mining Reports Q2 2026 Financial Results, Including Adjusted EBITDA(1) of US$31.7 Million and EPS of US$0.16/Share
Published on 08/14/2026 at 13:10, 1 hour 38 minutes ago SouthGobi Announces Second Quarter 2026 Unaudited Financial and Operating Results
Published on 08/14/2026 at 09:01, 5 hours 47 minutes ago Apex Announces Filing of Final Base Shelf Prospectus
Published on 08/14/2026 at 08:00, 6 hours 48 minutes ago Touchstone Exploration Announces Second Quarter 2026 Results and Operational Update
Published on 08/14/2026 at 14:35, 13 minutes ago Bitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock
Published on 08/14/2026 at 13:31, 1 hour 16 minutes ago Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks
Published on 08/14/2026 at 13:20, 1 hour 28 minutes ago Nagarro Management Board and Supervisory Board recommend the acceptance of the voluntary public takeover offer by Persistent
Published on 08/13/2026 at 18:00, 20 hours 48 minutes ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 21 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 21 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 20 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 20 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
